Paul S. Giacomini

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Eye tracking as a digital biomarker in neurodegenerative diseases.

Eye tracking as a digital biomarker in neurodegenerative diseases.

Journal: Journal of neurology

Published: November 26, 2025

Oculomotor indicators of cognitive performance are modulated by neurodegeneration.

Oculomotor indicators of cognitive performance are modulated by neurodegeneration.

Journal: Frontiers in neurology

Published: June 18, 2025

Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis.

Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis.

Journal: Neurology and therapy

Published: March 19, 2025

MOGAD and NMOSD: insights on patients' radiological and laboratory findings from a single UAE center.

MOGAD and NMOSD: insights on patients' radiological and laboratory findings from a single UAE center.

Journal: Frontiers in neurology

Published: August 14, 2024

Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.

Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: May 22, 2024

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

Journal: JAMA neurology

Published: March 11, 2024

From progression to progress: The future of multiple sclerosis.

From progression to progress: The future of multiple sclerosis.

Journal: Journal of central nervous system disease

Published: November 03, 2023

Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking software.

Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking software.

Journal: Frontiers in neurology

Published: June 21, 2023

Virtual Management of Multiple Sclerosis: Providing Access or Just Phoning it in?

Virtual Management of Multiple Sclerosis: Providing Access or Just Phoning it in?

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: April 17, 2023

Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease.

Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease.

Journal: Multiple sclerosis and related disorders

Published: January 18, 2023

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 12, 2023

Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions.

Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 29, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026